Your browser doesn't support javascript.
loading
The novel bacteriocin romsacin from Staphylococcus haemolyticus inhibits Gram-positive WHO priority pathogens.
Wolden, Runa; Ovchinnikov, Kirill V; Venter, Hermoine J; Oftedal, Thomas F; Diep, Dzung B; Cavanagh, Jorunn Pauline.
Afiliación
  • Wolden R; Department of Clinical Medicine, Faculty of Health Sciences, Research Group for Child and Adolescent Health, UiT The Arctic University of Norway , Tromsø, Norway.
  • Ovchinnikov KV; Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU) , Ås, Norway.
  • Venter HJ; Department of Clinical Medicine, Faculty of Health Sciences, Research Group for Child and Adolescent Health, UiT The Arctic University of Norway , Tromsø, Norway.
  • Oftedal TF; Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU) , Ås, Norway.
  • Diep DB; Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU) , Ås, Norway.
  • Cavanagh JP; Department of Clinical Medicine, Faculty of Health Sciences, Research Group for Child and Adolescent Health, UiT The Arctic University of Norway , Tromsø, Norway.
Microbiol Spectr ; 11(6): e0086923, 2023 Dec 12.
Article en En | MEDLINE | ID: mdl-37905822

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bacteriocinas / Antiinfecciosos Idioma: En Revista: Microbiol Spectr Año: 2023 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bacteriocinas / Antiinfecciosos Idioma: En Revista: Microbiol Spectr Año: 2023 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Estados Unidos